![]() |
市場調查報告書
商品編碼
1403378
安全針全球市場預測(~2030 年):按產品、應用、最終用戶和地區進行分析Safety Needles Market Forecasts to 2030 - Global Analysis By Product, Application, End User and By Geography |
2023年全球安全針市場規模為19.7億美元,預計2030年將達36.7億美元,預測期內複合年成長率為9.3%。
具有整合安全功能的醫用針頭稱為安全針頭。這些設備旨在透過減少與血源性病原體接觸的可能性來保護患者和醫護人員免受不必要的針刺傷害,並整體提高患者的安全。此外,安全針有多種類型和尺寸可供選擇,可為診所、醫院和其他醫療機構的各種醫療任務提供保護。
世界衛生組織預計,由於疫情後政府支出暫時增加,2020年全球衛生支出將飆升至近9兆美元。
患者賦權
賦予患者積極參與醫療保健決策的權利,包括選擇安全針頭等更安全的醫療設備,是推動安全針頭市場的主要因素。患者重視舒適性和安全性,因此他們更喜歡準確、不那麼不舒服、不太可能造成針刺傷害的安全針。此外,也鼓勵醫療保健提供者採用安全針頭解決方案,以滿足患者對更安全、更有效的醫療保健體驗的渴望。
初期成本高
這些產品的初期成本可能會阻止醫療保健提供者進行投資。此外,儘管與普通針頭相比,安全針頭由於安全性更高、減少針刺傷害並提高整體醫療保健安全性而通常價格更高,但短期的財務限制可能會阻礙普及。這可能會減緩市場滲透並限制獲得更安全的針頭選擇。
針頭安全的技術進步
與智慧型設備和電子健康記錄整合等創新功能可改善追蹤和合規性。降低針刺風險的針安全技術正在增強病患和醫護人員的信心。透過提供減少職場危害的實用解決方案,從而實現更安全的醫療實踐。此外,提高安全功能和促進市場成長的監管要求也推動了人們對血源性病原體相關風險的了解不斷增加。
缺乏意識
醫療機構和提供者通常不知道安全針頭的可用性和好處,這是安全針頭市場的缺點。醫護人員可能會繼續使用普通針頭而不考慮風險,從而可能減少安全針頭的使用。此外,其他因素包括對安全針的好處和應用的指導和培訓不足,這是市場擴張的主要障礙。
安全針市場受到了COVID-19疫情的影響。由於選擇性手術和非緊急治療被取消或推遲,對安全針頭的需求減少。全球供應鏈和製造流程的中斷進一步阻礙了這些儀器的生產和分銷。此外,由於醫療機構專注於控制感染及其後遺症,安全針頭和其他醫療用品受到的關注和資金較少,從而阻礙了該市場的成長。
靜脈導管針細分市場預計將成為預測期間最大的細分市場
由於靜脈治療的需求不斷增加,並且重點關注減少針刺傷害,靜脈導管針段預計將佔據最大的市場佔有率。針鎖定機構、易於使用的活化技術和改進的舒適性設計等先進技術經常被用來減少插入和拔除靜脈導管期間意外穿刺的可能性。此外,經常使用可伸縮和屏蔽設備來保護患者和醫護人員,這推動了這一領域的成長。
預計藥物傳輸領域在預測期內複合年成長率最高
預計藥物傳輸領域在預測期內複合年成長率最高。該領域的創新,例如使用具有內建安全功能的注射器和針頭的藥物輸送系統,使注射藥物變得更安全、更方便。這些進展對於需要自我給藥的疾病尤其重要,例如糖尿病和自體免疫疾病。此外,不斷變化的患者舒適度和安全標準以及醫療保健需求正在促使醫療保健專業人員和患者優先考慮更安全、更有效的藥物給藥方式,這正在推動該細分市場的成長。
由於為提高工人安全、減少針刺傷數量和阻止血液傳播疾病的傳播而實施的法規和激勵措施,歐洲在預測期內佔據了最大的市場佔有率。我做到了。該地區是強生、Covidien、Becton、Dickinson & Company 和 Smiths Medical 等主要企業的所在地,這些公司專注於產品創新和技術進步,以滿足不斷變化的安全標準。此外,安全針具的採用提供了資金、教育和培訓計劃,從而促進了該地區的成長。
由於醫療保健基礎設施的擴張、醫療旅遊業的激增以及對醫療保健行業職業安全的日益關注,預計亞太地區在預測期內的複合年成長率最高。印度、日本和中國等國家正在策略性地投資研發,以引進創新的安全針技術。此外,該市場的特點是感染疾病流行日益嚴重,醫療機構優先透過具有成本效益的安全針頭解決方案使用安全設備,這正在推動該地區的成長。我們正在推動。
According to Stratistics MRC, the Global Safety Needles Market is accounted for $1.97 billion in 2023 and is expected to reach $3.67 billion by 2030 growing at a CAGR of 9.3% during the forecast period. Medical needles with integrated safety features are known as safety needles. These devices are intended to shield patients and healthcare personnel against unwanted injuries caused by needle sticks, by lowering the chance of coming into contact with bloodborne pathogens, which improve patient safety in general. Furthermore, various types and sizes of safety needles are available to offer protection throughout a broad range of medical operations in clinics, hospitals, and other healthcare settings.
According to WHO, temporary boosts to government spending caused by the pandemic's aftermath amounted to a surge in global health expenditure close to US$9 trillion in 2020.
Patient empowerment, which involves patients who actively participate in their healthcare decisions, including the selection of safer medical devices like safety needles, is a major factor propelling the market for safety needles. They place a high value on comfort and safety, which makes them favor safety needles, which provide accuracy, less discomfort, and a lower chance of needlestick injuries. Furthermore, healthcare providers have been encouraged to embrace safety needle solutions that correspond with patient desires for safer and more effective healthcare experiences by the market's demand from informed and empowered patients.
The initial cost of these goods might hinder healthcare providers from making an investment. Additionally, compared to regular needles, safety needles are typically more expensive due to their improved safety features, and the uptake may be hampered by the short-term financial restrictions, despite the fact that they reduce needlestick injuries and increase overall healthcare safety; however, compared to regular needles, the cost of fabrication and manufacturing goes up when these safety elements are added. Therefore, this could result in delayed market penetration and restricted access to safer needle options.
Tracking and compliance have increased due to innovative features such as integration with smart devices and electronic health records. Lowering the risk of injuries caused by needles, needle safety technology has increased patient and healthcare staff confidence. This has led to safer medical practices by providing practical solutions to reduce workplace hazards. In addition, increased knowledge of the risks associated with blood borne pathogens had improved safety features and accelerated by regulatory requirements which thereby boosting this market's growth.
Healthcare institutions and providers are frequently unaware of the availability and advantages of safety needles, which is a drawback in the safety needle market. As healthcare workers might continue to use normal needles without thinking about the risks involved, this could lead to a decrease in the use of safety needles. Additionally, another factor contributing is inadequate instruction and training regarding the benefits and application of safety needles, which significantly hampers market expansion.
The safety needle market has been affected as a result of the COVID-19 outbreak. There was a decrease in the necessity for safety needles as elective surgeries and non-emergency treatments were cancelled or postponed. Production and distribution of these devices were further hampered by disruptions in the worldwide supply chain and manufacturing procedures. Furthermore, Safety needles and other medical supplies received less attention and funding as healthcare institutions concentrated on controlling the infection and its after-effects which consequently impeding this market growth.
The IV catheter needles segment is estimated to hold the largest share, due to the growing requirement for intravenous therapy and the emphasis on reducing needlestick injuries. Advancements such as needle locking mechanisms, user-friendly activation techniques, and improved designs for comfort are frequently applied to reduce the possibility of unintentional punctures during the insertion and removal of IV catheters. In addition, they frequently have retractable or shielding devices to protect patients and healthcare personnel, which is boosting this segment expansion.
The drug delivery segment is anticipated to have highest CAGR during the forecast period. Injecting drugs is now safer and more convenient due to innovations in this market area, such as syringes with built-in safety features and needle-based drug delivery systems. These developments are especially important for diseases like diabetes and autoimmune disorders that call for the self-administration of medication. Furthermore, due to changing patient comfort and safety standards as well as changing healthcare needs, healthcare professionals and patients prioritize safer and more efficient means of medicine administration thereby driving this segment growth.
Europe commanded the largest market share during the extrapolated period, owing to regulations and incentives that have been implemented to improve worker safety, lower the number of needles tick injuries, and stop the spread of blood borne illnesses. This region is home to major key players such as Johnson & Johnson, Covidien, Becton, Dickinson & Company, and Smiths Medical, which are focusing on product innovation and technological advancements to meet evolving safety standards. In addition, the adoption of safety needle items offers funding, education, and training programs, which thereby boost this region's growth.
Asia Pacific is expected to witness highest CAGR over the projection period, owing to the expanding healthcare infrastructure, a surge in medical tourism, and an increasing focus on occupational safety in the healthcare sector. Countries including India, Japan, and China are strategically investing in research and development to introduce innovative safety needle technologies. Furthermore, the market is characterized by a growing prevalence of infectious diseases, spurring healthcare facilities to prioritize the use of safety devices with cost-effective safety needle solutions, which are therefore driving this region's expansion.
Some of the key players in the Safety Needles Market include Boston Scientific Corporation, Medtronic, Plc., Smith Medical, Inc., Argon Medical devices, Inc., Terumo Corporation, Becton, Dickinson and Company, Abbott Laboratories, Novo Nordisk A/S, Nipro Medical Corporation, Eli Lily and Company and B. Braun Melsungen AG.
In October 2023, Boston Scientific Corporation announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication of the WaveWriter Alpha™ Spinal Cord Stimulator (SCS) Systems for the treatment of painful diabetic peripheral neuropathy (DPN), a complication of diabetes that can affect the lower extremities of the body.
In September 2023, Abbott and Bigfoot Biomedical announced a definitive agreement for Abbott to acquire Bigfoot, a leader in developing smart insulin management systems for people with diabetes.
In September 2023, Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., a privately held medical technology company that has developed and commercialized the Intracept® Intraosseous Nerve Ablation System to treat vertebrogenic pain, a form of chronic low back pain.
In April 2023, Abbott announced that it has completed the acquisition of Cardiovascular Systems, Inc., a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease.